FCF1
gene geneOn this page
Also known as CGI-35BkaUTP24
Summary
FCF1 (FCF1 rRNA-processing protein, HGNC:20220) is a protein-coding gene on chromosome 14q24.3, encoding rRNA-processing protein FCF1 homolog (Q9Y324). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. It is a common-essential gene (DepMap: required in 99.7% of cancer cell lines).
Enables RNA binding activity. Involved in ribosomal small subunit biogenesis. Part of small-subunit processome.
Source: NCBI Gene 51077 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 36 total
- Cancer dependency (DepMap): dependent in 99.7% of screened cell lines (common-essential)
- MANE Select transcript:
NM_015962
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20220 |
| Approved symbol | FCF1 |
| Name | FCF1 rRNA-processing protein |
| Location | 14q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CGI-35, Bka, UTP24 |
| Ensembl gene | ENSG00000119616 |
| Ensembl biotype | protein_coding |
| Entrez | 51077 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 4 protein_coding, 3 nonsense_mediated_decay, 1 retained_intron
ENST00000341162, ENST00000534938, ENST00000553615, ENST00000553673, ENST00000554064, ENST00000554590, ENST00000554973, ENST00000556814
RefSeq mRNA: 2 — MANE Select: NM_015962
NM_001318508, NM_015962
CCDS: CCDS81827, CCDS9832
Canonical transcript exons
ENST00000341162 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001374171 | 74734882 | 74738620 |
| ENSE00003479813 | 74713485 | 74713552 |
| ENSE00003530195 | 74723272 | 74723344 |
| ENSE00003569042 | 74715951 | 74716099 |
| ENSE00003590242 | 74713144 | 74713200 |
| ENSE00003612315 | 74714872 | 74714943 |
| ENSE00003632350 | 74734076 | 74734170 |
| ENSE00003659076 | 74732731 | 74732818 |
Expression profiles
Bgee: expression breadth ubiquitous, 282 present calls, max score 95.99.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 32.8095 / max 1551.1857, expressed in 1797 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 140578 | 32.8095 | 1797 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| germinal epithelium of ovary | UBERON:0001304 | 95.99 | gold quality |
| rectum | UBERON:0001052 | 93.53 | gold quality |
| monocyte | CL:0000576 | 93.40 | gold quality |
| amniotic fluid | UBERON:0000173 | 93.32 | gold quality |
| mononuclear cell | CL:0000842 | 93.31 | gold quality |
| leukocyte | CL:0000738 | 93.18 | gold quality |
| islet of Langerhans | UBERON:0000006 | 93.04 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 92.90 | gold quality |
| gingival epithelium | UBERON:0001949 | 92.83 | gold quality |
| stromal cell of endometrium | CL:0002255 | 92.77 | gold quality |
| calcaneal tendon | UBERON:0003701 | 92.49 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 92.45 | gold quality |
| endometrium | UBERON:0001295 | 91.77 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 91.62 | gold quality |
| gall bladder | UBERON:0002110 | 91.59 | gold quality |
| vermiform appendix | UBERON:0001154 | 91.41 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 91.10 | gold quality |
| mammary duct | UBERON:0001765 | 90.99 | gold quality |
| superficial temporal artery | UBERON:0001614 | 90.86 | gold quality |
| ganglionic eminence | UBERON:0004023 | 90.78 | gold quality |
| ventricular zone | UBERON:0003053 | 90.63 | gold quality |
| popliteal artery | UBERON:0002250 | 90.56 | gold quality |
| tibial artery | UBERON:0007610 | 90.55 | gold quality |
| hair follicle | UBERON:0002073 | 90.47 | gold quality |
| right coronary artery | UBERON:0001625 | 90.30 | gold quality |
| lymph node | UBERON:0000029 | 90.26 | gold quality |
| gingiva | UBERON:0001828 | 90.25 | gold quality |
| cortical plate | UBERON:0005343 | 90.23 | gold quality |
| ovary | UBERON:0000992 | 90.20 | gold quality |
| aorta | UBERON:0000947 | 90.18 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.59 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
72 targeting FCF1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-33A-5P | 99.99 | 68.62 | 1055 |
| HSA-MIR-33B-5P | 99.99 | 68.58 | 1062 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-6817-3P | 99.79 | 68.35 | 2126 |
| HSA-MIR-8076 | 99.78 | 68.52 | 1170 |
| HSA-MIR-4679 | 99.76 | 69.19 | 1229 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 99.7% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 1)
- hUTP24 inactivation leads to aberrant processing of 18S rRNA 2 nucleotides downstream of the normal A1 cleavage site. (PMID:26237581)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fcf1 | ENSDARG00000102333 |
| mus_musculus | Fcf1 | ENSMUSG00000021243 |
| rattus_norvegicus | Fcf1 | ENSRNOG00000004723 |
| drosophila_melanogaster | Bka | FBGN0010520 |
| caenorhabditis_elegans | F30A10.9 | WBGENE00009266 |
Paralogs (1): UTP23 (ENSG00000147679)
Protein
Protein identifiers
rRNA-processing protein FCF1 homolog — Q9Y324 (reviewed: Q9Y324)
All UniProt accessions (8): Q9Y324, G3V1S4, G3V2M5, G3V3N8, G3V5D2, G3V5L8, G3V5S9, Q4FZ45
UniProt curated annotations — full annotation on UniProt →
Function. Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome.
Subunit / interactions. Part of the small subunit (SSU) processome, composed of more than 70 proteins and the RNA chaperone small nucleolar RNA (snoRNA) U3.
Subcellular location. Nucleus. Nucleolus.
Similarity. Belongs to the UTP23/FCF1 family. FCF1 subfamily.
RefSeq proteins (2): NP_001305437, NP_057046* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002716 | PIN_dom | Domain |
| IPR006984 | Fcf1/UTP23 | Family |
| IPR029060 | PIN-like_dom_sf | Homologous_superfamily |
| IPR037503 | Fcf1_PIN | Domain |
Pfam: PF04900
UniProt features (4 total): chain 1, domain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7MQA | ELECTRON MICROSCOPY | 2.7 |
| 7MQ8 | ELECTRON MICROSCOPY | 3.6 |
| 7MQ9 | ELECTRON MICROSCOPY | 3.87 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y324-F1 | 83.59 | 0.48 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6790901 | rRNA modification in the nucleus and cytosol |
| R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol |
MSigDB gene sets: 103 (showing top):
GOBP_RIBOSOME_BIOGENESIS, GOBP_MATURATION_OF_SSU_RRNA, chr14q24, GOBP_MATURATION_OF_5_8S_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA, GOBP_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS, GOBP_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA, TIEN_INTESTINE_PROBIOTICS_24HR_UP, CREB_Q3, GOBP_MATURATION_OF_5_8S_RRNA, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, REACTOME_METABOLISM_OF_RNA, GOCC_PRERIBOSOME, GOCC_SMALL_SUBUNIT_PROCESSOME, GOCC_NUCLEOLUS, GOCC_RIBONUCLEOPROTEIN_COMPLEX
GO Biological Process (5): endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447), endonucleolytic cleavage in 5’-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480), ribosomal small subunit biogenesis (GO:0042274), rRNA processing (GO:0006364), ribosome biogenesis (GO:0042254)
GO Molecular Function (2): RNA binding (GO:0003723), protein binding (GO:0005515)
GO Cellular Component (4): nucleoplasm (GO:0005654), nucleolus (GO:0005730), small-subunit processome (GO:0032040), nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| rRNA processing in the nucleus and cytosol | 2 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2 |
| endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2 |
| ribonucleoprotein complex biogenesis | 2 |
| ribosome biogenesis | 2 |
| nuclear lumen | 2 |
| maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1 |
| RNA processing | 1 |
| rRNA metabolic process | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| nucleolus | 1 |
| preribosome | 1 |
| t-UTP complex | 1 |
| nuclear protein-containing complex | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1855 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FCF1 | DNTTIP2 | Q5QJE6 | 965 |
| FCF1 | FAF1 | Q9UNN5 | 847 |
| FCF1 | UTP3 | Q9NQZ2 | 804 |
| FCF1 | RCL1 | Q9Y2P8 | 728 |
| FCF1 | NOB1 | Q9ULX3 | 727 |
| FCF1 | UTP14A | Q9BVJ6 | 722 |
| FCF1 | NOMO2 | Q5JPE7 | 715 |
| FCF1 | NOMO3 | P69849 | 713 |
| FCF1 | PDCD11 | Q14690 | 708 |
| FCF1 | NOMO1 | P78421 | 696 |
| FCF1 | BMS1 | Q14692 | 690 |
| FCF1 | WDR46 | O15213 | 665 |
| FCF1 | HEATR1 | Q9H583 | 665 |
| FCF1 | UTP11 | Q9Y3A2 | 628 |
| FCF1 | KRR1 | Q13601 | 627 |
IntAct
50 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| BCCIP | FCF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPDYC | FCF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MECP2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| RPS2 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.530 |
| RPL18 | NOP56 | psi-mi:“MI:0914”(association) | 0.530 |
| RPL30 | RRP8 | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEB2 | POLRMT | psi-mi:“MI:0914”(association) | 0.530 |
| FCF1 | MAGEB2 | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEB2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| SRSF5 | CBX6 | psi-mi:“MI:0914”(association) | 0.530 |
| FCF1 | P4HA1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FCF1 | SULT2B1 | psi-mi:“MI:0914”(association) | 0.350 |
| SART3 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.350 |
| DGCR8 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.350 |
| CNBP | NOP56 | psi-mi:“MI:0914”(association) | 0.350 |
| GPATCH4 | NOP56 | psi-mi:“MI:0914”(association) | 0.350 |
| RBM4B | ZNF324 | psi-mi:“MI:0914”(association) | 0.350 |
| CACNA1C | IGLL5 | psi-mi:“MI:0914”(association) | 0.350 |
| GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 | |
| PRKRA | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.350 |
| SURF6 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL7A | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| SRSF1 | psi-mi:“MI:0914”(association) | 0.350 | |
| FGFBP1 | psi-mi:“MI:0914”(association) | 0.350 | |
| RPL35 | psi-mi:“MI:0914”(association) | 0.350 | |
| RPL31 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL11 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (140): FCF1 (Affinity Capture-MS), FCF1 (Affinity Capture-MS), FCF1 (Reconstituted Complex), FCF1 (Affinity Capture-MS), FCF1 (Affinity Capture-MS), FCF1 (Affinity Capture-MS), FCF1 (Affinity Capture-MS), FCF1 (Affinity Capture-MS), PPL (Affinity Capture-MS), TREX2 (Affinity Capture-MS), SULT2B1 (Affinity Capture-MS), ENDOU (Affinity Capture-MS), EVPL (Affinity Capture-MS), IVL (Affinity Capture-MS), SERPINB5 (Affinity Capture-MS)
ESM2 similar proteins: A0JN39, A4FV84, B5DGH9, D2K760, D2SW95, D5LHJ0, F4JGR5, O14929, O60832, P11497, P23514, P42932, P50990, P53618, Q05AY2, Q13085, Q1LUA8, Q28559, Q2YDN6, Q32PD0, Q39097, Q3B8M3, Q3ZCI9, Q5M939, Q5R4J9, Q5R922, Q5RAP1, Q5RFQ0, Q5SWU9, Q5XIY6, Q5ZIA5, Q66HV4, Q6DRI1, Q6EE31, Q6P7L9, Q8BY71, Q8IWZ6, Q8IZH2, Q8K2G4, Q9BSC4
Diamond homologs: O13610, O74862, Q05498, Q08DU1, Q32PD0, Q55GM5, Q5RFQ0, Q9CTH6, Q9Y324, Q12339, Q9BRU9, Q9CX11
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 57 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Eukaryotic Translation Initiation | 5 | 41.7× | 8e-07 |
| Cap-dependent Translation Initiation | 5 | 41.7× | 8e-07 |
| SARS-CoV-1 modulates host translation machinery | 5 | 41.7× | 8e-07 |
| Peptide chain elongation | 11 | 37.7× | 1e-13 |
| Viral mRNA Translation | 11 | 37.7× | 1e-13 |
| Eukaryotic Translation Elongation | 5 | 37.6× | 1e-06 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 11 | 37.3× | 1e-13 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 5 | 36.7× | 1e-06 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| cytoplasmic translation | 11 | 37.7× | 1e-12 |
| ribosomal small subunit biogenesis | 6 | 25.3× | 1e-05 |
| translation | 11 | 20.9× | 5e-10 |
| rRNA processing | 5 | 13.1× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
36 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 22 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1075 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:74713225:G:T | donor_gain | 1.0000 |
| 14:74713257:G:GT | donor_gain | 1.0000 |
| 14:74713549:GGCT:G | donor_gain | 1.0000 |
| 14:74713550:GCTG:G | donor_gain | 1.0000 |
| 14:74713605:GA:G | donor_gain | 1.0000 |
| 14:74713606:A:G | donor_gain | 1.0000 |
| 14:74714870:A:AG | acceptor_gain | 1.0000 |
| 14:74714871:G:GA | acceptor_gain | 1.0000 |
| 14:74714871:GTAAA:G | acceptor_gain | 1.0000 |
| 14:74714939:GAAGT:G | donor_gain | 1.0000 |
| 14:74714942:GT:G | donor_gain | 1.0000 |
| 14:74715949:A:AG | acceptor_gain | 1.0000 |
| 14:74715950:G:GG | acceptor_gain | 1.0000 |
| 14:74716098:GT:G | donor_gain | 1.0000 |
| 14:74732725:CTACA:C | acceptor_loss | 1.0000 |
| 14:74732726:TACAG:T | acceptor_loss | 1.0000 |
| 14:74732727:ACAGG:A | acceptor_loss | 1.0000 |
| 14:74732728:CAG:C | acceptor_loss | 1.0000 |
| 14:74732729:A:AG | acceptor_gain | 1.0000 |
| 14:74732729:AG:A | acceptor_gain | 1.0000 |
| 14:74732729:AGGA:A | acceptor_loss | 1.0000 |
| 14:74732730:G:C | acceptor_loss | 1.0000 |
| 14:74732730:G:GG | acceptor_gain | 1.0000 |
| 14:74732730:GG:G | acceptor_gain | 1.0000 |
| 14:74732814:CTCAG:C | donor_loss | 1.0000 |
| 14:74732815:TCAG:T | donor_loss | 1.0000 |
| 14:74732816:CAG:C | donor_loss | 1.0000 |
| 14:74732817:AG:A | donor_loss | 1.0000 |
| 14:74732818:G:GC | donor_loss | 1.0000 |
| 14:74732820:T:A | donor_loss | 1.0000 |
AlphaMissense
1306 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:74715973:T:C | F56L | 1.000 |
| 14:74715975:T:A | F56L | 1.000 |
| 14:74715975:T:G | F56L | 1.000 |
| 14:74715987:T:A | N60K | 1.000 |
| 14:74715987:T:G | N60K | 1.000 |
| 14:74716016:T:A | L70H | 1.000 |
| 14:74716016:T:C | L70P | 1.000 |
| 14:74716019:T:A | V71D | 1.000 |
| 14:74716021:G:C | D72H | 1.000 |
| 14:74716022:A:C | D72A | 1.000 |
| 14:74716022:A:T | D72V | 1.000 |
| 14:74716023:T:A | D72E | 1.000 |
| 14:74716023:T:G | D72E | 1.000 |
| 14:74716025:C:T | T73I | 1.000 |
| 14:74716029:C:A | N74K | 1.000 |
| 14:74716029:C:G | N74K | 1.000 |
| 14:74716030:T:C | F75L | 1.000 |
| 14:74716031:T:C | F75S | 1.000 |
| 14:74716032:T:A | F75L | 1.000 |
| 14:74716032:T:G | F75L | 1.000 |
| 14:74716034:T:A | I76N | 1.000 |
| 14:74716038:C:A | N77K | 1.000 |
| 14:74716038:C:G | N77K | 1.000 |
| 14:74716042:T:C | S79P | 1.000 |
| 14:74716043:C:A | S79Y | 1.000 |
| 14:74716043:C:T | S79F | 1.000 |
| 14:74716086:T:G | C93W | 1.000 |
| 14:74716088:T:C | L94P | 1.000 |
| 14:74716099:T:C | C98R | 1.000 |
| 14:74723273:T:G | C98W | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000124777 (14:74712467 A>G), RS1000189115 (14:74718623 G>A), RS1000231869 (14:74718909 T>C), RS1000337272 (14:74724604 T>G), RS1000727506 (14:74718270 T>C,G), RS1000777200 (14:74732444 C>T), RS1000816969 (14:74723480 G>A,C), RS1001122403 (14:74723049 T>C), RS1001152739 (14:74737991 C>A), RS1001329237 (14:74719512 A>G), RS1001560726 (14:74725522 G>A), RS1001597350 (14:74719860 A>C), RS1001840898 (14:74735854 A>T), RS1001892890 (14:74724063 C>A), RS1002073442 (14:74719250 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005237_3 | Mood instability | 1.000000e-06 |
| GCST005238_3 | Mood instability | 3.000000e-09 |
| GCST010002_156 | Refractive error | 7.000000e-25 |
| GCST010396_47 | Gut microbiota (bacterial taxa, hurdle binary method) | 7.000000e-06 |
| GCST012354_47 | Anxiety | 3.000000e-16 |
| GCST012355_13 | Depression | 3.000000e-18 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008475 | mood instability measurement |
| EFO:0007874 | gut microbiome measurement |
| EFO:0009863 | anxiety measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects expression, affects cotreatment, decreases expression, increases abundance, increases expression | 3 |
| Arsenic | affects methylation, affects cotreatment, decreases expression, increases abundance | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Cadmium Chloride | decreases expression, increases abundance, increases expression | 2 |
| bisphenol A | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| entinostat | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| ICG 001 | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Irinotecan | affects expression | 1 |
| Temozolomide | decreases expression | 1 |
| Atrazine | increases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Coumestrol | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Valproic Acid | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
| Particulate Matter | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.